￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
The objective response rate of Tagrisso combined with sarvotinib in NSCLC patients with high MET overexpression was 49%_ Kanghule

2025-10-19 11:44:20

Check Details
How long does it take for Osimertinib to take effect and how to judge whether it is effective?

2025-10-19 11:44:20

Check Details
How many tablets of osimertinib should be taken every day and how many years can it be taken?

2025-10-19 11:44:20

Check Details
What should I do if I miss a dose of Osimertinib? What are the dietary taboos?

2025-10-19 11:44:20

Check Details
How much does it cost to pay for Osimertinib through medical insurance?

2025-10-19 11:44:20

Check Details
What should you pay attention to when taking dacomitinib?

2025-10-19 11:44:20

Check Details
Does Dacomitinib affect the liver? How long does it take to stop taking it?

2025-10-19 11:44:20

Check Details
How to take dacomitinib, should it be taken before or after meals?

2025-10-19 11:44:20

Check Details
Can dacomitinib be purchased with medical insurance? How many years can one live taking dacomitinib?

2025-10-19 11:44:20

Check Details
Is it okay to take one pill a day of crizotinib? Can I reduce the dose if there is a large reaction?

2025-10-19 11:44:20

Check Details
How many days does it take for crizotinib to take effect, and how long does it take for it to become resistant?

2025-10-19 11:44:20

Check Details
How often should I recheck after taking crizotinib? Do I need to pay attention to my diet?

2025-10-19 11:44:20

Check Details
Category
相关知识